 Largely democratized in terms of population information, embryonic stem cells are known for their strong capacity for expansion and differentiation into cardiomyocytes, endothelial cells and cardiac fibroblasts.However, if non autologous, immunosuppression therapy is associated with such treatment.Hence, research has been focused on induced pluripotent stem cells (iPSCs) from somatic human tissue.